Posted on October 25th, 2011 by msequeira
Julie Bauman, MD, MPH, a head and neck cancer specialist at the University of New Mexico Cancer Center, has been recognized by the National Cancer Institute (NCI) as one of the nation’s top clinical researchers. Dr. Bauman is among just a handful of outstanding physicians around the country honored with the NCI’s Cancer Clinical Investigator Team Leadership Award for 2011.
The recognition of Dr. Bauman’s exceptional leadership in cancer clinical trials and commitment to advancing care for patients comes with a grant award of $50,000 per year for two years, designed to further her clinical research activities. The award is thus a win for New Mexicans facing head and neck cancers, Dr. Bauman’s area of expertise and the focus of her highly successful efforts to open new clinical trials in New Mexico.
“Dr. Bauman couldn’t be more deserving of this award,” said Cheryl Willman, MD, Director and CEO of the UNM Cancer Center. “It is an intensely competitive honor that only a few clinicians nationwide achieve each year. The fact that the UNM Cancer Center has had two recipients since the award’s inception in 2009 underscores the excellence of the physicians and researchers who serve the people of New Mexico.”
Melanie Royce, MD, PhD, a nationally known breast cancer specialist who leads the UNM Cancer Center’s Multidisciplinary Breast Cancer Program, received the NCI Clinical Investigator Award in 2009.
“This is a great honor and privilege,” said Dr. Bauman, Assistant Professor of Hematology/Oncology and Director of the Multidisciplinary Head and Neck Cancer Working Group at the UNM Cancer Center, as well as Chair of the Protocol Monitoring and Review Committee at the New Mexico Cancer Care Alliance. “I am grateful for the opportunity to expand our efforts to design and conduct high-quality clinical trials in head and neck cancer – aiming to improve survival and survivorship in this devastating disease.”
Trained dually in medical oncology and public health, Dr. Bauman has focused her academic career on clinical and translational research in head and neck cancer. She joined the UNM Cancer Center in 2008. Shortly thereafter, she founded the Multidisciplinary Head and Neck Cancer Working Group, which has opened 13 clinical trials of new treatments for head and neck cancer patients in just two years. These include a multicenter study evaluating a new treatment combination for incurable head and neck cancer, and a translational study investigating a promising new therapeutic strategy based on scientific discoveries made at the UNM Cancer Center. Before her arrival, there were no open treatment trials for head and neck cancer patients.
The NCI created the Cancer Clinical Investigator Team Leadership Award in 2009 as a way to support and recognize outstanding physician-scientists whose leadership is crucial to the conduct of clinical trials nationwide. Such trials constitute the final phases of a rigorous process of development and testing that all new cancer therapies must undergo. The awards, available to investigators at all NCI-designated cancer centers that participate in NCI-funded collaborative clinical trials, ultimately support a shared culture in which researchers collaborate freely across disciplines, institutions and programs to advance the design and conduct of cancer clinical trials.
About the UNM Cancer Center
The UNM Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute (NCI)-designated cancer center in the state. One of just 66 NCI-designated cancer centers nationwide, the UNM Cancer Center is recognized for its scientific excellence, contributions to cancer research and delivery of medical advances to patients and their families. It is home to 85 board-certified oncology physicians representing every cancer specialty and 126 research scientists hailing from prestigious institutions such as MD Anderson, Johns Hopkins and the Mayo Clinic. The UNM Cancer Center treats more than 65 percent of the adults and virtually all of the children in New Mexico affected by cancer, from every county in the state. Last year, it provided care to nearly 16,000 patients. The Center’s research programs are supported by $60 million annually in federal and private funding. Learn more at http://cancer.unm.edu.
You must be logged-in to the site to post a comment.